FDA deadline to comment on international rescheduling of cannabis nears
The U.S. Food and Drug Administration (FDA) reopened a comment period for public input in preparation for the international discussion…
News September 11
Latest In: FDA
Multistate marijuana company Curaleaf posts higher revenues, losses
Curaleaf Holdings, a multistate cannabis operator, reported revenue of $48.5 million in the second quarter, more than triple…
News August 28
FDA: CBD shouldn’t be a controlled substance, but treaties require it
The U.S. Food and Drug Administration noted that cannabidiol shouldn’t be a controlled substance, but international treaties require…
News October 1
FDA approves cannabis-derived medicine; DEA must weigh in
The U.S. Food and Drug Administration has approved a CBD drug - a landmark decision that will trigger…
News June 25FDA sends another round of warnings to CBD producers
Federal drug authorities have sent another round of warning letters to CBD producers about making health claims. The…
News November 1Senators Put Pressure on DEA to Reschedule Marijuana
A group of U.S. Democratic senators is putting pressure on the U.S. Drug Enforcement Agency to remove marijuana…
News June 28RI Cannabis Oil Firm Strikes Research Partnership
Two Rhode Island companies – a cannabis oil manufacturer and a biotech farm – are collaborating on tests…
News June 13FDA Grants U.K. Firm Incentives to Develop Cannabis-Based Drug
U.S. regulators granted GW Pharmaceuticals’ cannabis-based epilepsy drug “orphan” status, enabling the company to receive tax credits and…
News April 25Study Results Send GW Pharma’s Stock Soaring
A British maker of cannabis-based drugs revealed some sorely needed good news on Monday, announcing that an epilepsy medicine…
News March 14Featured
1
Latest Sponsored
